Health Technology Regulation and Assessment

HTA plays a crucial role in informing decision-making on the reimbursement of medical technologies globally. It is a multidisciplinary activity which studies the clinical and the cost effectiveness of new pharmaceuticals or any other medical interventions, as well as how health policy might be impacted by the new technology and what the social and ethical implications might be for patients and the wider society.

Our current Health Technology Regulation & Assessment research projects:

Impact-HTA: Improved methods and actionable tools for enhancing HTA

DIAGMAL: Economic evaluation of an innovative simple molecular test for the diagnosis of malaria in different endemic and health settings in sub-Sahara Africa

DaRe2THINK: Testing the hypothesis that DOACs are cost-effective in patients with AF at low or intermediate risk of stroke by using an ambitious and innovative approach

Health Innovation Next Generation Payment & Pricing Models

Informing Medicare Prescription Drug Price: Negotiations Assessing the impact of the Inflation Reduction Act

Visit the Medical Technology Research Group website for more information on our LSE Consulting projects

Visit our past projects archive to find out about our past HTA research impacts